A Study to Evaluate the Efficacy and Safety of Tanfanercept (HL036) in Dry Eye Disease
Clinical trial NCT06400589 · SUSPENDED
Trial details
- NCT number
- NCT06400589
- Sponsor
- HanAll BioPharma Co., Ltd.
- Status
- SUSPENDED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-01
- Primary completion
- 2025-08-01
- Enrollment
- 750
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.